MICRO FLOW CYTOMETRY

Use of flow cytometry for quantitative cell, bead and other particle differentiation has been increasing in the three decades since the basic technology was first introduced. Today's commercially-available systems are relied upon for an array of applications including monitoring in cancer and HIV infection. To date, however, flow cytometry has meant large, expensive instruments that require trained personnel and substantial volumes of sample and reagents in order to obtain results.

Micronics' most advanced product in development is a portable flow cytometer, known as the Microcytometer^® System. This system uses a droplet of whole blood to provide a complete blood count ("CBC") analysis to determine whether or not the end user has experienced a change in white blood cells as a result of pathogen exposure. Sample to result is achieved in less than 5 minutes.

The Microcytometer® System is the first portable system that will work directly from the whole blood sample without any preparatory steps. It will greatly minimize reagent use and contain the sample, reagents and waste on-card. As a result, Micronics expects to be poised with a first-of-its-kind device responsive to the growing market applications for flow cytometry at point of care.

No license under the patents to use the technologies incorporated in Micronics’ Active or Access cards is conveyed expressly or by implication to the purchaser by the purchase of this product. A license to use any of the Micronics’ patented microfluidics technologies for research and development may be available for certain product applications. Further information on licenses required to practice the Micronics’ patented technologies may be obtained by contacting the Director, Business Development, Micronics, Inc. 8463 154th Avenue N.E. Redmond, WA 98052; or by calling 425.895.9197.